Page last updated: 2024-08-23

vindesine and Kaposi Sarcoma

vindesine has been researched along with Kaposi Sarcoma in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bakker, PJ; Danner, SA; Kroon, FP; Meenhorst, PL; Muusers, A; Sprenger, HG; ten Napel, CH; van Leusen, R; Veenhof, CH	1
Accurso, V; Ammassari, A; Antinori, A; Cusini, M; Fasan, M; Garavelli, LP; Repetto, L; Tavio, M; Tirelli, U; Vaccher, E	1
Besnard, V; Boillot, O; Claudy, A; Euvrard, S; Faure, M; Françès, C; Kanitakis, J; Mion, F	1

Trials

2 trial(s) available for vindesine and Kaposi Sarcoma

Article	Year
Treatment of poor prognosis epidemic Kaposi's sarcoma with doxorubicin, bleomycin, vindesine and recombinant human granulocyte-monocyte colony stimulating factor (rh GM-CSF). European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Male; Middle Aged; Neutropenia; Prognosis; Prospective Studies; Recombinant Proteins; Sarcoma, Kaposi; Treatment Outcome; Vindesine	1995
Combination chemotherapy with doxorubicin, bleomycin, and vindesine for AIDS-related Kaposi's sarcoma. Cancer, 1996, May-15, Volume: 77, Issue:10 Topics: Acquired Immunodeficiency Syndrome; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Female; Humans; Male; Middle Aged; Prospective Studies; Sarcoma, Kaposi; Survival Analysis; Vindesine	1996

Article

Year

Treatment of poor prognosis epidemic Kaposi's sarcoma with doxorubicin, bleomycin, vindesine and recombinant human granulocyte-monocyte colony stimulating factor (rh GM-CSF).

European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:2

Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Male; Middle Aged; Neutropenia; Prognosis; Prospective Studies; Recombinant Proteins; Sarcoma, Kaposi; Treatment Outcome; Vindesine

1995

Combination chemotherapy with doxorubicin, bleomycin, and vindesine for AIDS-related Kaposi's sarcoma.

Cancer, 1996, May-15, Volume: 77, Issue:10

Topics: Acquired Immunodeficiency Syndrome; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Female; Humans; Male; Middle Aged; Prospective Studies; Sarcoma, Kaposi; Survival Analysis; Vindesine

1996

Other Studies

1 other study(ies) available for vindesine and Kaposi Sarcoma

Article	Year
Kaposi's sarcoma after liver transplantation. Dermatology (Basel, Switzerland), 1996, Volume: 193, Issue:2 Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Base Sequence; DNA, Viral; Female; Follow-Up Studies; Herpesviridae; Humans; Immunosuppressive Agents; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Muromonab-CD3; Prognosis; Sarcoma, Kaposi; Skin Neoplasms; Survival Rate; Vindesine	1996

Article

Year

Kaposi's sarcoma after liver transplantation.

Dermatology (Basel, Switzerland), 1996, Volume: 193, Issue:2

Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Base Sequence; DNA, Viral; Female; Follow-Up Studies; Herpesviridae; Humans; Immunosuppressive Agents; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Muromonab-CD3; Prognosis; Sarcoma, Kaposi; Skin Neoplasms; Survival Rate; Vindesine

1996